Key takeaway
Pooling 9 articles covering 10 cohort studies (180,566 participants, 20,119 hypertension cases), the highest dietary magnesium intake was linked to 8% lower hypertension risk than the lowest (RR 0.92, 95% CI 0.86-0.98). Blood magnesium showed only a marginal link (RR 0.91, 0.80-1.02), and observational cohorts cannot prove magnesium itself lowers blood pressure.
Study design
Observational meta-analysis
Reading basis
Published abstract
Reading focus
Design & applicability
The research question
Earlier cohort studies disagreed on whether eating more magnesium, or having higher blood magnesium, relates to lower hypertension risk. The authors pooled prospective cohort studies to test the link and to estimate how risk changes with each extra amount of magnesium.
Who and how
Systematic review and dose-response meta-analysis of prospective cohort studies. PubMed, EMBASE and the Cochrane Library were searched from October 1951 through June 2016 for studies reporting effect estimates with 95% confidence intervals for hypertension across more than two categories of dietary magnesium intake and/or serum magnesium. Random-effects models combined the estimates. Nine articles (six on dietary intake, two on serum magnesium and one on both) were eligible, from ten cohort studies.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Highest versus lowest dietary magnesium intake was associated with lower hypertension risk (RR 0.92, 95% CI 0.86-0.98).
- 2Each 100 mg/day increase in magnesium intake was associated with a 5% lower risk (RR 0.95, 95% CI 0.90-1.00); the interval reaches 1.00, so this is borderline.
- 3For serum magnesium, the association was marginally significant and not clear-cut (RR 0.91, 95% CI 0.80-1.02).
- 4The meta-analysis pooled 20,119 hypertension cases among 180,566 participants.
Limits & uncertainty
- 1All data are from observational cohorts, so people who eat more magnesium (from vegetables, nuts, whole grains) may differ in other healthy habits that explain part of the link.
- 2Very few studies assessed serum magnesium (three of the nine articles), so that result is weak and imprecise.
- 3The abstract does not report heterogeneity, how intake was measured or the countries included, which limits judgement of reliability.
- 4The dose-response result is borderline, with a confidence interval touching 1.00.
What to take from it
Getting magnesium from a varied diet with vegetables, legumes, nuts and whole grains fits this finding, and its effect on blood pressure is small. This evidence does not support taking magnesium supplements to prevent or treat hypertension; discuss supplements and blood pressure management with your clinician.
Reading your own data
A food log can estimate your usual magnesium intake from foods, though app databases are approximate. If you measure blood pressure at home, use the same validated cuff, rest first, and look at the average of readings over weeks, because a small diet effect is hard to see in single measurements.
How to read this evidence
Pooling observational studies does not remove their confounding. Check overlapping cohorts and whether relative effects are being confused with absolute benefits.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Background
The findings of prospective cohort studies are inconsistent regarding the association between dietary magnesium intake and serum magnesium concentration and the risk of hypertension. We aimed to review the evidence from prospective cohort studies and perform a dose-response meta-analysis to investigate the relationship between dietary magnesium intake and serum magnesium concentrations and the risk of hypertension.
Methods
We searched systematically PubMed, EMBASE and the Cochrane Library databases from October 1951 through June 2016. Prospective cohort studies reporting effect estimates with 95% confidence intervals (CIs) for hypertension in more than two categories of dietary magnesium intake and/or serum magnesium concentrations were included. Random-effects models were used to combine the estimated effects.
Results
Nine articles (six on dietary magnesium intake, two on serum magnesium concentration and one on both) of ten cohort studies, including 20,119 cases of hypertension and 180,566 participates, were eligible for inclusion in the meta-analysis. We found an inverse association between dietary magnesium intake and the risk of hypertension [relative risk (RR) = 0.92; 95% CI: 0.86, 0.98] comparing the highest intake group with the lowest. A 100 mg/day increment in magnesium intake was associated with a 5% reduction in the risk of hypertension (RR = 0.95; 95% CI: 0.90, 1.00). The association of serum magnesium concentration with the risk of hypertension was marginally significant (RR = 0.91; 95% CI: 0.80, 1.02).
Conclusions
Current evidence supports the inverse dose-response relationship between dietary magnesium intake and the risk of hypertension. However, the evidence about the relationship between serum magnesium concentration and hypertension is limited.
Sources & attribution
Dose-response relationship between dietary magnesium intake, serum magnesium concentration and risk of hypertension: a systematic review and meta-analysis of prospective cohort studies.
Han H, Fang X, Wei X, Liu Y, Jin Z, Chen Q, Fan Z, Aaseth J, Hiyoshi A, He J, Cao Y.
Nutrition journal · 2017-05-05
DOI: 10.1186/s12937-017-0247-4 ↗PubMed · 28476161 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people
Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.
Journal of the American Heart Association
Five exercise types lowered resting blood pressure, isometric training the most
Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.
British Journal of Sports Medicine
A salt substitute lowered stroke, major cardiovascular events and death in rural China
In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.
The New England Journal of Medicine
Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation
Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.
The New England Journal of Medicine

